Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015315
Filing Date
2024-11-12
Accepted
2024-11-12 16:10:28
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20240930x10q.htm   iXBRL 10-Q 1730730
2 EX-31.1 mrns-20240930xex31d1.htm EX-31.1 13395
3 EX-31.2 mrns-20240930xex31d2.htm EX-31.2 13523
4 EX-32.1 mrns-20240930xex32d1.htm EX-32.1 7721
5 GRAPHIC mrns-20240930x10q004.jpg GRAPHIC 14134
  Complete submission text file 0001558370-24-015315.txt   7517464

Data Files

Seq Description Document Type Size
6 EX-101.SCH mrns-20240930.xsd EX-101.SCH 63459
7 EX-101.CAL mrns-20240930_cal.xml EX-101.CAL 56207
8 EX-101.DEF mrns-20240930_def.xml EX-101.DEF 203764
9 EX-101.LAB mrns-20240930_lab.xml EX-101.LAB 502886
10 EX-101.PRE mrns-20240930_pre.xml EX-101.PRE 347197
80 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20240930x10q_htm.xml XML 1166345
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 241448183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)